Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for August 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Public Sector Funds Large Part of State Obesity-Related Costs
MONDAY, Aug. 29 (HealthDay News) -- Between 22 and 55 percent of U.S. state-level obesity-related costs are financed by the public sector via Medicare and Medicaid, according to a study published online June 16 in Obesity.
Self-Efficacy Tied to Achieving Physical Activity Goals in RA
MONDAY, Aug. 29 (HealthDay News) -- For patients with rheumatoid arthritis (RA) having self-efficacy at baseline is tied to achieving physical activity goals, which has a direct effect on uality of life, according to a study published online Aug. 25 in Arthritis Care & Research.
Loss of Jobs Means Loss of Health Coverage for Many in U.S.
MONDAY, Aug. 29 (HealthDay News) -- For American adults who lose their health insurance coverage when they lose their jobs, the majority remain uninsured, delay getting needed health care or prescriptions, and report financial difficulties paying medical bills, according to a report published online Aug. 24 by The Commonwealth Fund.
Complementary Medicine Used More by Health Care Workers
FRIDAY, Aug. 26 (HealthDay News) -- U.S. health care workers, especially health care providers, are more likely to use complementary and alternative medicine (CAM) than the general, employed U.S. population, according to a study published online Aug. 22 in Health Services Research.
Pharmaceutical Ads Often Don't Adhere to U.S. FDA Guidelines
THURSDAY, Aug. 25 (HealthDay News) -- Physician-targeting pharmaceutical advertisements have low rates of adherence to U.S. Food and Drug Administration (FDA) guidelines and provide inadequate information for safe prescribing, according to a study published online Aug. 17 in PLoS One.
NSAID Intolerance Indicative of Intolerance to Etoricoxib
MONDAY, Aug. 22 (HealthDay News) -- Patients with urticaria and/or angioedema with hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) may also be intolerant to etoricoxib, according to a study published online Aug. 11 in Allergy.
Fibronectin-Aggrecan Complex IDs Epidural Steroid Response
MONDAY, Aug. 22 (HealthDay News) -- In patients receiving lumbar epidural steroid injection (ESI) for radiculopathy from lumbar herniated nucleus pulposus (HNP), fibronectin-aggrecan complex (FAC) can act as an accurate and independent biomarker of response to ESI, according to a study published in the Aug. 15 issue of Spine.
Methotrexate Lowers Response to Pneumococcal Vaccine
MONDAY, Aug. 22 (HealthDay News) -- In patients with rheumatoid arthritis (RA) or spondylarthropathy (SpA), treatment with methotrexate (MTX), but not with tumor necrosis factor (TNF) blockers, reduces antibody response after vaccination with pneumococcal conjugate vaccine, according to a study published online Aug. 10 in Arthritis & Rheumatism.
Traditional Risk Factors Up Early RA Cardiovascular Events
FRIDAY, Aug. 19 (HealthDay News) -- Traditional cardiovascular (CV) risk factors increase the risk of new cardiovascular events (CVEs) in patients with rheumatoid arthritis (RA), with disease activity increasing the risk, and treatment with disease modifying antirheumatic drugs (DMARDs) decreasing the risk, according to a study published online Aug. 15 in Arthritis Research & Therapy.
CDC: 2010/2011 Flu Vaccination Coverage Studied
THURSDAY, Aug. 18 (HealthDay News) -- Influenza vaccination coverage among health care personnel (HCP) and pregnant women in the 2010/2011 influenza season was similar to coverage for the 2009/2010 season, according to two reports in the Aug. 19 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
High Cumulative Malpractice Risk for All Physicians
THURSDAY, Aug. 18 (HealthDay News) -- Physicians in all specialties have a high cumulative risk of facing a malpractice claim by age 65; although most claims do not lead to indemnity payments, according to a study published in the Aug. 18 issue of the New England Journal of Medicine.
Pegloticase Tied to Lower Uric Acid Levels in Chronic Gout
TUESDAY, Aug. 16 (HealthDay News) -- Pegloticase lowers uric acid levels in patients with refractory chronic gout, according to a study published in the Aug. 17 issue of the Journal of the American Medical Association.
Altered Movement Biomechanics in Obese Tied to Osteoarthritis
MONDAY, Aug. 15 (HealthDay News) -- Obese individuals have altered movement strategies during everyday movements, including walking and sit-to-stand, according to a review published online Aug. 3 in Obesity Reviews.
Psychiatric Comorbidity Affects Costs in Severe Back Pain
FRIDAY, Aug. 12 (HealthDay News) -- Patients with severe back pain undergoing disc surgery have high direct and indirect costs, which are influenced by psychiatric comorbidity, according to a study published in the July issue of The Spine Journal.
Three Distinct Aspects of Knee Shape ID'd in Osteoarthritis
FRIDAY, Aug. 12 (HealthDay News) -- In women, knees with osteoarthritis (OA) have wider femoral and tibial bone, extend more during radiography, and have an elevated lateral tibial plateau, according to a study published online Aug. 2 in Arthritis & Rheumatism.
Obesity Ups Risk of Incident Gout, Tied to Earlier Onset
THURSDAY, Aug. 11 (HealthDay News) -- Obesity is a strong risk factor for incident gout, and is correlated with a younger age of gout onset, according to a study published in the August issue of Arthritis Care & Research.
Environmental Factors Tied to Psoriatic Arthritis Development
WEDNESDAY, Aug. 10 (HealthDay News) -- Environmental factors, including infections that require antibiotic treatment, injuries, and occupations that involved lifting heavy weights, are significantly associated with the development of psoriatic arthritis (PsA), according to a study published in the August issue of Arthritis Care & Research.
Tofacitinib With Methotrexate Efficacious in Active RA
TUESDAY, Aug. 9 (HealthDay News) -- Tofacitinib with methotrexate (MTX) is effective, tolerable, and safe for patients with active rheumatoid arthritis (RA) and inadequate response to MTX alone, according to a study published in the August issue of Arthritis Care & Research.
Delayed Care for Rheumatoid Arthritis in Europe Studied
TUESDAY, Aug. 9 (HealthDay News) -- European patients with rheumatoid arthritis (RA) experience an average delay of 24 weeks from the time of symptom onset to the assessment by a rheumatologist, according to a study published online Aug. 7 in the Annals of the Rheumatic Diseases.
Soy Isoflavones Don't Prevent Menopausal Bone Loss
TUESDAY, Aug. 9 (HealthDay News) -- Soy isoflavone tablets, administered once daily, do not prevent bone loss or menopausal symptoms in women during the first five years of menopause, according to a study published in the Aug. 8/22 issue of the Archives of Internal Medicine.
Oral Contraceptives Beneficial in Inflammatory Polyarthritis
MONDAY, Aug. 8 (HealthDay News) -- In women with inflammatory polyarthritis (IP), use of oral contraceptives (OCs) before or during symptom onset is associated with beneficial functional outcome, according to a study published in the August issue of Arthritis & Rheumatism.
Cost of Interacting With Payers Higher in U.S. Than Canada
FRIDAY, Aug. 5 (HealthDay News) -- Physician practices in the United States spend considerably more on interactions with health plans than Canadian practices, according to a study published in the August issue of Health Affairs.
Neurologic Lesions Common in Reverse Shoulder Arthroplasty
WEDNESDAY, Aug. 3 (HealthDay News) -- Peripheral neurologic lesions following reverse shoulder arthroplasty are common but usually temporary, and may be attributed to arm lengthening, according to a study published in the July 20 issue of The Journal of Bone & Joint Surgery.
Subset of Regulatory T Cells Suppresses Germinal Center
MONDAY, Aug. 1 (HealthDay News) -- A subset of regulatory Foxp3+ T cells (T-reg), which express CXCR5 and Bcl-6, localizes to the germinal center in mice and humans and may inhibit germinal center reactions, according to an experimental study published online July 24 in Nature Medicine.
Knee Arthroplasty Unaffected by Patellar Resurfacing
MONDAY, Aug. 1 (HealthDay News) -- Neither patellar resurfacing nor the design of the prosthetic affects the clinical outcome of total knee arthroplasty, according to a study published in the July 20 issue of The Journal of Bone & Joint Surgery.
Copyright © 2011 ScoutNews, LLC. All rights reserved.
|Previous: August 2011 Briefing - Pulmonology||Next: August 2011 Briefing - Surgery|
Reader comments on this article are listed below. Review our comments policy.